Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Tuesday, February 02, 2021
Takeda announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera for a total value of $825 million USD.
read more
Takeda announced the completion of its previously-announced sale of a portfolio of select OTC and prescription pharmaceutical assets in a number of countries.
read more
Wednesday, March 04, 2020
Takeda Pharmaceutical announced the completion of its previously-announced sale of a portfolio of select products to STADA Arzneimittel for a total value of $660 million USD.
read more
Wednesday, January 06, 2016
Takeda Pharmaceutical has announced the acquisition of a biologics manufacturing facility located in Brooklyn Park, Minnesota, U.S. from Baxalta US Inc.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Takara Bio Europe announced the expansion of its Gothenburg facility with the addition of a custom manufacturing lab, which came into operation on October 1st.
read more
Takara Bio Inc. announced a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents ...
read more
Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to custom model design and generation services.
read more
Taconic Biosciences has announced the successful implementation of its Rapid Restart™ program.
read more
Wednesday, October 28, 2020
Taconic Biosciences has announced immediate humanized ACE2 mouse model availability for COVID-19 research.
read more
Taconic Biosciences announced local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
read more
Friday, February 14, 2020
Taconic Biosciences has announced its humanized immune system mice models are now being produced in Europe.
read more
Monday, September 28, 2020
T-knife GmbH and Catalent announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor program.
read more
Wednesday, November 25, 2020
Sysmex America announced it will add the CellaVision® DC-1 to its portfolio of CellaVision products for low-volume hematology labs.
read more